European heart group issues guidelines on 4 new anticoagulants

05/3/2013 | TheHeart.org (Montreal) (free registration)

The European Heart Rhythm Association of the European Society of Cardiology has released practice guidelines for the use of the oral anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation. The guide includes clinical scenarios and information on managing bleeding risks.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI